Legal settlements with large pharmaceutical companies resulted in billions of dollars in opioid abatement funding, which are being distributed to healthcare organizations through state and federal grants through 2030.
Legal settlements with large pharmaceutical companies resulted in billions of dollars in opioid abatement funding, which are being distributed to healthcare organizations through state and federal grants through 2030.
